Document is current
Any future updates will be listed below
-
Authors
Li, Jie
Yang, Han
Qi, Yixin
Yu, Peng
Han, Xiahui
Zhang, Zongliang
Zhao, Kai
Yin, Xinbao
Zhu, Guanqun
Yan, Xuechuan
Jiang, Zaiqing
Ma, Xuezhen
He, Tianzhen
Wang, Ke
-
Funding
Funding for this research was provided by:
Natural Science Foundation of China (82200759, 82100557)
Large Instruments Open Foundation of Nantong University (KFJN2375)
Qingdao Science and Technology Benefiting People Demonstration Project (24-1-8-smjk-4-nsh)
- License Information
-
More Information
Article History
Received: 4 June 2024
Accepted: 24 September 2024
First Online: 8 October 2024
Declarations
:
: The authors declare no competing interests.
: The studies in which human RCC tumor samples were collected were approved by the ethical committees of the Affiliated Hospital of Qingdao University (QYFYWZLL 26556). Written consent was obtained from all patients. For mouse studies, all procedures were approved by the Ethics Committee of the Medical Animal Laboratory of the Affiliated Hospital of Qingdao University (AHQU-MAL20240301). The experimental protocol was conducted in accordance with the relevant guidelines and regulations of the Basel Declaration. This study is reported in accordance with the ARRIVE guidelines ().
